New diagnoses of prostate cancer decreased according to study from MPH alum

December 1, 2015

New prostate cancer diagnoses declined by almost 30% in the first year after the U.S. Preventive Services Task Force (USPSTF) recommended against routine screening PSA tests, a review of a national database showed. An analysis by disease stage at diagnosis showed that the number of new diagnoses of intermediate- and high-risk prostate cancer also decreased, which could have potentially ominous implications if the trend persists, Daniel A.